Related Experiment Video
Updated: May 1, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
5.9K
Wandering and dementia.
Gabriele Cipriani1, Claudio Lucetti, Angelo Nuti
1Neurology Unit, Hospital of Viareggio, Lido di Camaiore, Lucca, Italy.
Summary
Wandering in dementia patients is a distressing issue with unknown causes and limited treatment evidence. Addressing related psychological issues may help manage this common behavioral problem.
Area of Science:
- Gerontology
- Neurology
- Psychiatry
Background:
- Wandering is a common behavioral problem in dementia patients.
- It is distressing for patients and caregivers and a major reason for nursing home admission.
- The causes of wandering are poorly understood.
Purpose of the Study:
- To review the phenomenon of wandering behavior in patients with dementia.
- To identify associated negative outcomes and potential management strategies.
Main Methods:
- Searches were conducted using Medline and Google Scholar for articles, chapters, and books published since 1975.
- Keywords included 'wandering', 'behavioural and psychological symptoms', 'dementia', 'nursing', and 'elopements'.
- Relevant references from initial search results were reviewed.
Main Results:
- Wandering encompasses various behaviors, including aimless movement.
- It is linked to numerous negative outcomes.
- Evidence for effective pharmacological and non-pharmacological interventions is limited.
Conclusions:
- Wandering in dementia is a complex issue with significant negative impacts.
- Further research is needed to understand its aetiology.
- Managing coexistent psychopathology may help ameliorate wandering behavior.
Related Concept Videos
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:30Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K